「クリア」とはどういう意味ですか？
その動物は突然変異を持っていません。病気を発症することはありません そしてそれを伝えません。
犬 若年死亡を伴う心筋症（CJM）
The Cardiomyopathy With Juvenile Mortality (CJM) DNA test in dogs is essential for early detection of this hereditary heart condition. CJM causes severe heart muscle disease leading to sudden death in young dogs, making genetic screening crucial for breeders and pet owners. By identifying carriers and affected dogs, the CJM DNA test helps prevent the spread of this fatal disorder within breeding lines. Early diagnosis through this test allows for better management and care of at-risk dogs. Reliable and accurate, the CJM DNA test supports responsible breeding practices and promotes healthier canine populations. Ensure your dog’s health and future by opting for the Cardiomyopathy With Juvenile Mortality DNA test today. Protect your pet with advanced genetic testing designed to save lives.
略語 ： CJM
解析された変異: YARS2 c.1054G>A
継承 ： 常染色体劣性
頭字語
CJM
観測周波数
臨床的重症度
臨床分類
心血管疾患
解析された変異
YARS2 c.1054G>A
p.(E352K)
p.(E352K)
継承のモード
常染色体劣性 （完了）
テストの概要:
The DNA test for Cardiomyopathy With Juvenile Mortality (CJM) in dogs helps identify carriers of this genetic condition. CJM is a serious heart disease that can cause sudden death in young dogs. Early detection through testing allows breeders to make informed decisions and reduce the risk of passing the mutation to offspring. This test is especially important for breeds known to be affected by CJM. Responsible breeding based on DNA results promotes healthier future generations of dogs.
パックから入手可能: Basic
この DNA 検査はパックから含まれています Basic — これもパックの一部です Basic, Standard, Advanced, Complete。
DNA テスト パックを見る →動物の繁殖戦略や健康戦略に最適なパックをお選びください。
Understanding Cardiomyopathy With Juvenile Mortality (CJM) in Dogs
Cardiomyopathy With Juvenile Mortality (CJM) is a serious and often fatal heart condition that primarily affects young dogs. It is characterized by the degeneration of heart muscle, leading to impaired heart function and, in severe cases, sudden cardiac death. CJM typically presents in dogs under the age of two, making early detection and intervention crucial for improving outcomes.
Pathophysiology of CJM
The underlying cause of CJM involves genetic mutations that disrupt the normal structure and function of cardiac muscle cells. As the disease progresses, the heart becomes progressively weaker, resulting in decreased cardiac output and potential rhythm disturbances. These changes can lead to symptoms such as lethargy, weakness, and exercise intolerance, which may rapidly escalate to life-threatening conditions.
Clinical Signs and Diagnosis
Dogs affected by CJM may exhibit a range of clinical signs, including coughing, difficulty breathing, and fainting episodes. Due to the rapid progression of the disease, it is essential for pet owners to seek veterinary attention promptly if they notice any concerning symptoms. Diagnosis typically involves a combination of physical examinations, echocardiography, and electrocardiograms to assess heart function and identify abnormalities.
Management and Treatment Options
While there is currently no cure for CJM, management strategies aim to improve the quality of life and prolong survival for affected dogs. Treatment may include medications to support heart function, reduce fluid buildup, and manage arrhythmias. Additionally, lifestyle modifications, such as restricted exercise and regular veterinary check-ups, play an important role in managing the condition effectively.
Importance of Genetic Testing
Genetic testing for CJM is a valuable tool for identifying at-risk dogs and guiding breeding decisions. By understanding the genetic predisposition to this condition, breeders can make informed choices to reduce the incidence of CJM in future generations. Furthermore, early identification of affected individuals allows for timely intervention and better management of the disease.
結論
Cardiomyopathy With Juvenile Mortality (CJM) represents a significant health concern in young dogs, emphasizing the importance of awareness, early detection, and genetic testing. By recognizing the signs of this condition and seeking appropriate veterinary care, pet owners can help ensure their dog's health and well-being. Ongoing research and advancements in genetic testing continue to provide hope for better management and prevention strategies for CJM.
試験に認められた品種: 若年死亡を伴う心筋症（CJM）
- Belgian Malinois
- Belgian Sheepdog
- Belgian Shepherd Dog
- Lakenois
🧬 Interpretation of genotypes CJM
遺伝子型
状態
🟡 N/N
ノンキャリア - リスクなし
🟡 N/CJM
キャリア - リスクなし
❌ CJM/CJM
影響を受ける – 危険にさらされる
FAQ: 解釈を理解する
「キャリア」って本気なの？
いいえ、その動物は通常健康ですが、突然変異をその動物に伝える可能性があります。 子孫。
動物が「影響を受けている」場合はどうなりますか?
それは2つの突然変異したコピーを持っています。臨床症状は以下に応じて予想されます 病気。飼育してはいけません。
なぜ男性/女性で違いがあるのでしょうか？
一部の病気は性と関連があるため、その発現は性別によって異なります。 動物の性別。
子孫を予測する
N/N (%e3%83%8e%e3%83%b3%e3%82%ad%e3%83%a3%e3%83%aa%e3%82%a2）
N/CJM (キャリア）
CJM/CJM (影響を受ける）
DNA検査に関するよくある質問
この DNA 検査では何が検出されますか?
This DNA test detects the mutation associated with Cardiomyopathy With Juvenile Mortality (CJM) in order to identify clear, carrier, or at-risk animals.
なぜ繁殖動物を検査するのでしょうか?
DNA検査は、ブリーダーがより安全な交配を計画し、子孫に突然変異が伝わるリスクを軽減するのに役立ちます。
このテストの継承モードは何ですか?
このテストで報告される継承モードは常染色体劣性です。
このテストではどの変異が分析されますか?
This test analyses the mutation YARS2 c.1054G>A.
保菌動物は必ず影響を受けますか?
必ずしもそうとは限りません。解釈は、遺伝パターンと結果として生じる遺伝子型によって異なります。
参考文献
Gurtner Corinne, Hug Petra, Kleiter Miriam, Köhler Kernt, Dietschi Elisabeth, Jagannathan Vidhya, Leeb Tosso. YARS2 Missense Variant in Belgian Shepherd Dogs with Cardiomyopathy and Juvenile Mortality. Genes (Basel). 2020 Mar 14;11(3):313. doi: 10.3390/genes11030313.